Healthcare Discovery longevity science reckoning coordination paradigm showing aging as interconnected biological systems
| |

Longevity Science Is Having a Reckoning: Why the Next Breakthrough May Not Be a Drug

Scientists at the 2nd World Congress on Targeting Longevity in Berlin delivered an uncomfortable verdict in April 2026: despite decades of discoveries, longevity science has stalled on clinical translation. The…

Skeletal muscle releasing myokine signals toward the brain during strength training for longevity | Healthcare Discovery
| | |

Myokines and the Muscle Brain Axis: What 2026 Research Reveals About Strength Training and Longevity

New 2026 research on myokines, the signaling proteins released by contracting muscle, shows why strength training is a cognitive intervention. Here is what the science reveals about irisin, cathepsin B,…

Healthcare Discovery cardiac amyloidosis ATTR therapy revolution 2026 showing transthyretin protein misfolding and heart failure treatment
| | |

The Cardiac Amyloidosis Revolution: How ATTR Therapies Are Rewriting Heart Failure Treatment in 2026

For decades, cardiac amyloidosis was a diagnosis cardiologists whispered and patients rarely heard. In 2026, tafamidis, acoramidis, RNA silencers, and a CRISPR gene editing therapy are transforming ATTR care and…

Deep slow-wave sleep driving glymphatic brain cleanup as cerebrospinal fluid clears amyloid and tau
| | |

Deep Sleep and the Brain’s Glymphatic System: What 2026 Sleep Science Reveals About Your Nightly Cleanup

New glymphatic research reveals that deep slow wave sleep drives the brain’s nightly clearance of amyloid and tau, with 2026 data linking sleep architecture to long term dementia risk and…

Three-day fasting threshold molecular transformation research | Healthcare Discovery
| | |

Time-Restricted Eating in 2026: What Circadian Science Reveals About When You Eat

A new wave of circadian biology research from Satchin Panda, Courtney Peterson, and the NIH is reshaping how scientists think about meal timing. Time-restricted eating influences glucose, blood pressure, autophagy,…

The Daily Rounds: Longevity & Health Care Brief | April 16, 2026
|

The Daily Rounds: Longevity & Health Care Brief | April 16, 2026

🔬 Senolytics Reduce Epigenetic Age: Lab data show senolytic compounds measurably lower biological age markers, with human pilot trials now exploring effects on mobility and cognition. 🧠 FTL1 Protein Drives Memory Decline: Scientists identified a specific protein that weakens brain cell connections with age, opening a new therapeutic target for cognitive preservation. 🤖 Novo Nordisk + OpenAI Partnership: The pharma giant is applying frontier AI to compress drug discovery timelines and accelerate patient access to novel medicines. 🦠 CAG-170 Bacteria Linked to Gut Health: A globally validated analysis found this rare bacterial group is a marker of health, producing B12 and stabilizing the gut ecosystem. 😴 Solar Jet Lag and Liver Cancer: A new federally backed study will probe whether circadian misalignment is an upstream cause of the most common form of liver cancer.

AI-powered protein dynamics research advancing drug discovery at MIT and ASU
| | |

AI-Designed Drugs Are Entering Human Trials: Inside the Quiet Pharmaceutical Revolution of 2026

For the first time in pharmaceutical history, molecules designed almost entirely by artificial intelligence are surviving Phase 2 trials in real patients. From Insilico’s rentosertib to Isomorphic Labs’ multi-billion dollar…